Ceska, Richard <br/><br/>
PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.  [electronic resource] 

 -  Atherosclerosis  Jan 2003 
 - 195-6 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/s0021-9150(02)00313-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Atorvastatin<br/>Biomarkers--blood<br/>C-Reactive Protein--analysis<br/>Coronary Disease--blood<br/>Fenofibrate--pharmacology<br/>Heptanoic Acids--pharmacology<br/>Humans<br/>Hyperlipidemias--blood<br/>Hypolipidemic Agents--pharmacology<br/>Pregnancy-Associated Plasma Protein-A--analysis<br/>Pyrroles--pharmacology